Weight Loss Injection Review: What Clinical Trials and Regulators Have Found

What the phase-3 trial data found, and why it matters for your decision

Any credible review of weight loss injections starts with the trial evidence, because these are medicines, not supplements. Semaglutide 2.4mg (Wegovy) was assessed in the STEP 1 trial, published in the New England Journal of Medicine, which followed adults with obesity over 68 weeks. Participants using the injection alongside lifestyle changes lost, on average, around 15% of their body weight, compared with roughly 2–3% on placebo.

Tirzepatide (Mounjaro) was assessed across the SURMOUNT programme. SURMOUNT-1, which randomised 2,539 adults with obesity over 72 weeks, reported average body-weight reductions of around 20–21% at the 15mg maintenance dose. In 2025 the head-to-head SURMOUNT-5 trial compared tirzepatide directly against semaglutide 2.4mg; tirzepatide produced greater average weight loss across the study period. NICE reviewed this body of evidence and published separate appraisals recommending both medicines, tirzepatide in TA1026 (December 2024) and semaglutide in TA875 (March 2023).

Those headline percentages reflect averages across trial populations. Individual results vary considerably depending on starting weight, adherence, dose reached, and what else someone changes in their diet and activity levels. The trial data tells us these medicines produce clinically meaningful weight loss for many people; it does not tell us what will happen for you personally, which is precisely why a prescriber's assessment comes first.

What regulators have said about safety, the evidence base beyond efficacy

Both injections carry a Black Triangle designation from the MHRA, meaning additional post-market safety monitoring is ongoing. The most common side effects across both medicines are gastrointestinal: nausea, vomiting, diarrhoea and constipation appear most often, especially in the first few weeks or after a dose increase. Most people find these settle as the body adjusts.

Pancreatitis is a less common but serious risk. In January 2026 the MHRA issued a Drug Safety Update specifically flagging acute pancreatitis for GLP-1 medicines: anyone experiencing severe, persistent stomach pain (particularly pain that radiates through to the back) should seek urgent medical attention. The Yellow Card scheme allows patients to report suspected side effects directly to the MHRA, and doing so genuinely contributes to the evidence base for these medicines.

For women using oral contraceptives, tirzepatide specifically may reduce pill absorption during the first four weeks of treatment and for four weeks after each dose increase; an additional non-oral method is recommended during those windows. That is the kind of detail a prescriber covers before you start, not something to piece together from a forum thread. You can read an overview of how weight loss injections work and what the treatment journey looks like before you reach that conversation.

How to read online reviews of weight loss injections, and what to treat with caution

Online reviews of weight loss injections vary wildly in quality. Some reflect genuine experiences under proper clinical supervision; others come from people who obtained medicines without a prescription, from unverified sources, at doses that no prescriber had sanctioned. Those accounts are not reviews of the medicine, they are reviews of a different, riskier situation entirely.

A practical check: does the reviewer describe a clinical consultation before starting? Did someone review their current medicines, their medical history, their weight? Were they monitored through dose increases? If not, what they experienced may have little bearing on what you would experience under proper care. You can find structured perspectives on weight loss injection experiences in the UK that reflect supervised treatment, and if you are specifically researching what people have reported about B12 injections for weight loss, it is worth reading those accounts alongside the clinical evidence for context.

It is also worth knowing that reviews sourced from price-comparison sites sometimes sit alongside sellers offering these medicines without a prior clinical assessment. The MHRA has warned publicly about counterfeit pens sold online; in 2025 alone approximately 20 million doses of illegally traded weight loss medicines were seized, some containing insulin rather than the labelled active ingredient. That context belongs in any honest review of this treatment category.

For context on what supervised private treatment costs and what is included in a legitimate service, the weight loss injection prices page sets out what to expect and what headline prices often leave out.

What a legitimate, clinically supervised review of your suitability looks like

The licensed eligibility criteria for both medicines are clear: adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. But meeting a BMI number is the beginning of the assessment, not the end of it.

A proper clinical review covers current medicines (interactions, absorption considerations), relevant medical history, contraindications, and which injection (or indeed whether any injection) is the right fit. If you are researching all your options, it is worth looking at the weight loss injection beginning with R to understand how it compares with the better-known GLP-1 medicines before you speak to a prescriber. Our clinical team at nume approaches every consultation this way, with a GPhC-registered prescriber reading your answers personally. The pen arriving at your door the next morning, tracked by DPD, is the end of that process, not the shortcut around it.

If you are weighing up which medicine might suit you, the weight loss treatment overview covers both options side by side, and patients who have looked into B12 alongside GLP-1 treatment sometimes find the vitamin B12 injections weight loss reviews page useful for separating realistic expectations from the more exaggerated claims that circulate online. More detailed questions are answered on the FAQs page. And if you would like a prescriber to review your specific situation, you can check your eligibility through a free consultation, there is no obligation, and it starts the same day you submit it.